$ATRA Atara Biotherapeutics, Inc. Insider Trading Week 46/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. in week 46/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 4,146 | 0 | 2,764 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.00 | 7,000 | 105,000 | 256,236 | 263.2 K to 256.2 K (-2.66 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 4,146 | 0 | 263,236 | 259.1 K to 263.2 K (+1.60 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 553 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 13.36 | 1,604 | 21,429 | 342,530 | 344.1 K to 342.5 K (-0.47 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 344,134 | 343.3 K to 344.1 K (+0.24 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,908 | 0 | 3,938 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 5,908 | 0 | 743,675 | 737.8 K to 743.7 K (+0.80 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 0.00 | 7,212 | 0 | 12,019 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 14.20 | 3,290 | 46,718 | 163,052 | 166.3 K to 163.1 K (-1.98 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 0.00 | 7,212 | 0 | 166,342 | 159.1 K to 166.3 K (+4.53 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | M | 0.00 | 1,602 | 0 | 2,137 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Buy | M | 0.00 | 1,602 | 0 | 30,503 | 28.9 K to 30.5 K (+5.54 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 5,132 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 128,654 | 121 K to 128.7 K (+6.36 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 817 | 0 | 1,362 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,549 | 0 | 1,548 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 14.20 | 1,184 | 16,813 | 109,738 | 110.9 K to 109.7 K (-1.07 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 817 | 0 | 110,922 | 110.1 K to 110.9 K (+0.74 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,549 | 0 | 110,105 | 108.6 K to 110.1 K (+1.43 %) |
| Nov 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.41 | 2,200 | 29,502 | 419,778 | 422 K to 419.8 K (-0.52 %) |
| Nov 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.53 | 2,200 | 29,766 | 421,978 | 424.2 K to 422 K (-0.52 %) |